Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Executive Board Elections


New ESMO Executive Board members elected by Society members

Executive Board members elected by ESMO members

ESMO members were recently invited to vote for the ESMO President (2025-2026) and three Directors (2023-2024) who will commence their mandate as members of the ESMO Executive Board as of 1 January 2023.

Solange Peters, ESMO President, would like to thank all those who voted in the elections* and is pleased to announce the names of the newly elected Executive Board members who will guide ESMO in the coming years.

ESMO President 2025-2026: Fabrice André

Fabrice André, MD, PhD, Head of Research Division, and Professor in the Department of Medical Oncology at Gustave Roussy Cancer Campus, France.

His presidential vision is shaped by his dual professional identity as a medical oncologist specialised in breast cancer and as an academic with a focus on biotechnologies. 

As ESMO President, I will seek to push digital technologies and biotechnologies further up on the scientific agenda in order to find solutions to reduce the complexity of treatment decisions that physicians face and to decrease the burden of treatment for patients thanks to precision medicine.

Fabrice André

ESMO Director of Education 2023-2024: Nadia Harbeck

Nadia Harbeck, MD, PhD, Director of the Breast Center and Chair for Conservative Oncology at the Dept. of OB&GYN, LMU University Hospital, Munich, Germany.

My belief is that ESMO needs to continue to bring education to the community and not necessarily the community to an educational venue. As Director of Education I will look to address the heterogeneity of our colleagues’ educational needs as outlined in ESMO’s vision #ONEoncology community by offering tailored educational formats and having our faculty represent the diversity that ESMO stands for, regarding balance of regions, gender, professional experience, and oncological disciplines.

Nadia Harbeck

ESMO Director of Membership 2023-2024: Evandro de Azambuja

Evandro de Azambuja, MD, PhD, Jules Bordet Institute, Brussels, Belgium.

The focus of my mission is to further increase ESMO’s visibility in different countries by working closely with the Membership Committee, Young Oncologists Committee and the Women for Oncology Committee. During my mandate, I will promote ESMO while keeping in mind diversity and advocating that cancer care should be equally provided to all patients irrespective of their geographical area.

Evandro de Azambuja

ESMO Director of Public Policy 2023-2024: Jean-Yves Blay

Jean-Yves Blay, MD, PhD, Professor of Medicine at the University Claude Bernard in Lyon, General Director of the Centre Leon Berard, the Comprehensive Cancer Centre of Lyon France, and  President of the UNICANCER Federation.

As Director of Public Policy, I look forward to building on ESMO expertise. Our policy will aim to reduce inequalities for routine care and research in EU countries by matching the pace of precision medicine, proposing organisational guidance, developing international continuous medical education, working with national and international cancer plans, increasing health care professional numbers, with high-quality continuous training.

Jean-Yves Blay

*In accordance with Article 17, Paragraph 2 of the ESMO Bylaws, the required minimum participation quorum of 10% has been exceeded.

Last update: June 2022

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.